SIGNIFICANT ACCOUNTING POLICIES (Tables)

6 Months Ended

Dec. 31, 2018

Accounting Policies [Abstract]

Summary of Revenue by Solution

The components of revenues by solution which reflect a disaggregation of revenue by contract type are as follows (in thousands):

	Three-Months Ended December 31,
	2018		% Total		2017(2)		% Total
REVENUES BY SOLUTION:
Mailbacks	$	8,039	64.8	%	$	6,796	61.2	%
Route-based pickup services	2,078		16.8	%	1,830		16.5	%
Unused medications	1,350		10.9	%	1,317		11.8	%
Third party treatment services	78		0.6	%	337		3.0	%
Other (1)	849		6.9	%	839		7.5	%
Total revenues	$	12,394	100.0	%	$	11,119	100.0	%
	Six-Months Ended December 31,
	2018		% Total		2017(2)		% Total
REVENUES BY SOLUTION:
Mailbacks	$	13,646	60.2	%	$	12,261	58.9	%
Route-based pickup services	4,206		18.5	%	3,591		17.3	%
Unused medications	2,989		13.2	%	2,489		12.0	%
Third party treatment services	180		0.8	%	771		3.7	%
Other (1)	1,666		7.3	%	1,690		8.1	%
Total revenues	$	22,687	100.0	%	$	20,802	100.0	%

(1) The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items with single performance obligations.

(2) Certain prior year amounts have been reclassified to conform to current year presentation.

Schedule of Impact of New Accounting Guidance

The impact of adopting the new accounting guidance on the Company's condensed consolidated balance sheet as of December 31, 2018 was as follows (in thousands):

	December 31, 2018
	As Reported			Adjustments			Balance Without Adoption
Current contract asset	$	250		$	(250	)	$	—
Prepaid and other current assets	717			(22		)	695
Total current assets	19,096			(272		)	18,824
Contract asset, net of current portion	37			(37		)	—
Total assets	35,620			(309		)	35,311
Current contract liability(1)	2,132			11			2,143
Total current liabilities	7,255			11			7,266
Contract liability, net of current portion(1)	337			—			337
Total liabilities	9,068			11			9,079
Accumulated deficit	(870		)	(320		)	(1,190		)
Total stockholders' equity	26,552			(320		)	26,232
Total liabilities and stockholders' equity	$	35,620		$	(309	)	$	35,311

(1): Prior period contract liabilities were referred to as deferred revenue.

The impact of adopting the new accounting guidance on the Company's condensed consolidated statement of operations for the three and six months ended December 31, 2018 was as follows (in thousands):

	Three Months Ended December 31, 2018						Six-Months Ended December 31, 2018
	As Reported		Adjustments		Balance Without Adoption		As Reported		Adjustments		Balance Without Adoption
Revenues	$	12,394	$	69	$	12,463	$	22,687	$	104	$	22,791
Cost of revenues	8,403		27		8,430		15,344		64		15,408
Gross profits	3,991		42		4,033		7,343		40		7,383
Selling, general and administrative	2,959		9		2,968		5,985		22		6,007
Operating income	827		33		860		952		18		970
Net income	$	779	$	33	$	812	$	849	$	18	$	867